The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
NCT06027554
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to test the effects of MitoQ supplementation in older adults and frail older adults with physical dysfunction and/or cognitive dysfunction.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Frailty
- Mild Cognitive Impairment
- Aging
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 65 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- UConn Health
- Last updated on ClinicalTrials.gov
- August 12, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Connecticut · 1
- UConn Health · Farmington, CT
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.